{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:23:34Z","timestamp":1791426214950,"version":"4.3.3"},"reference-count":116,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.beem.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T19:48:15Z","timestamp":1529351295000},"page":"805-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Non classical complications of primary hyperparathyroidism"],"prefix":"10.1016","volume":"32","author":[{"given":"I.","family":"Chiodini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.06.006_bib1","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2018.06.006_bib3","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital","volume":"274","author":"Cope","year":"1966","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.006_bib5","first-page":"13","article-title":"Causes of death in patients previously operated on for primary hyperparathyroidism","volume":"74","author":"Ronni-Sivula","year":"1985","journal-title":"Ann Chir Gynaecol"},{"key":"10.1016\/j.beem.2018.06.006_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"Premature death in patients operated on for primary hyperparathyroidism","volume":"14","author":"Hedback","year":"1990","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib7","first-page":"N68","article-title":"Clinical presentation of primary hyperparathyroidism in Europe\u2013nationwide cohort analysis on mortality from nonmalignant causes","volume":"17","author":"Nilsson","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.006_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.06.006_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","article-title":"Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans","volume":"12","author":"Fliser","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.beem.2018.06.006_bib10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib11","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2015-3202","article-title":"Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis","volume":"100","author":"McMahon","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib12","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-10-0201","article-title":"Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy","volume":"163","author":"Farahnak","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib14","doi-asserted-by":"crossref","first-page":"408295","DOI":"10.1155\/2012\/408295","article-title":"L.\u00a0Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results","volume":"2012","author":"Luigi","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.06.006_bib16","doi-asserted-by":"crossref","first-page":"e7255","DOI":"10.1097\/MD.0000000000007255","article-title":"Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: a systematic review and meta-analysis","volume":"96","author":"Best","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.beem.2018.06.006_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4158\/EP.14.2.155","article-title":"Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis","volume":"14","author":"Streeten","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2018.06.006_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.111.081307","article-title":"Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy","volume":"126","author":"Osto","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2018.06.006_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00259-009-1316-5","article-title":"Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes","volume":"37","author":"Marini","year":"2010","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.beem.2018.06.006_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib21","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2011-2107","article-title":"Aortic valve calcification in mild primary hyperparathyroidism","volume":"97","author":"Iwata","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-12-0124","article-title":"Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism","volume":"167","author":"Walker","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/eje.0.1470453","article-title":"Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism","volume":"147","author":"Nuzzo","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib25","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1210\/jc.2002-021837","article-title":"Ultrasound evaluation of carotid artery in primary hyperparathyroidism","volume":"88","author":"Fallo","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10554-006-9166-8","article-title":"Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism","volume":"23","author":"Baykan","year":"2007","journal-title":"Int J Cardiovasc Imag"},{"key":"10.1016\/j.beem.2018.06.006_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2265.2012.04485.x","article-title":"Endothelial function in mild primary hyperparathyroidism","volume":"78","author":"Carrelli","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.06.006_bib28","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib29","first-page":"1815","article-title":"Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism","volume":"85","author":"Barletta","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.1992.tb02279.x","article-title":"Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism","volume":"37","author":"Rosenqvist","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/eci.12038","article-title":"Arrhythmias in primary hyperparathyroidism evaluated by exercise test","volume":"43","author":"Pepe","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.beem.2018.06.006_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-13-0293","article-title":"Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test","volume":"169","author":"Pepe","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib34","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1007\/s10067-016-3450-3","article-title":"Musculoskeletal manifestations of primary hyperparathyroidism","volume":"35","author":"Pappu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.beem.2018.06.006_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10067-014-2735-7","article-title":"Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients","volume":"34","author":"Ferrari","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.beem.2018.06.006_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0039-6060(05)80224-7","article-title":"Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism","volume":"117","author":"Chou","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.006_bib37","first-page":"296","article-title":"Association between myotonic dystrophy and primary hyperparathyroidism","volume":"22","author":"Bell","year":"1994","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.beem.2018.06.006_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1507\/endocrj1954.38.457","article-title":"Prevalence of chondrocalcinosis in patients with primary hyperparathyroidism in Japan","volume":"38","author":"Yashiro","year":"1991","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.beem.2018.06.006_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0272-6386(12)80324-6","article-title":"Erosive spondyloarthropathy in primary hyperparathyroidism without renal failure","volume":"20","author":"Barzilay","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2018.06.006_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ard.36.2.146","article-title":"Chondrocalcinosis in primary hyperparathyroidism. Influence of age, metabolic bone disease and parathyroidectomy","volume":"36","author":"Pritchard","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.beem.2018.06.006_bib41","first-page":"460","article-title":"Calcium pyrophosphate crystal deposition disease and hyperparathyroidism. A controlled, prospective study","volume":"5","author":"Rynes","year":"1978","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.beem.2018.06.006_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.surg.2006.12.004","article-title":"Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up)","volume":"141","author":"Caillard","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.006_bib43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00268-002-6623-y","article-title":"Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism","volume":"26","author":"Pasieka","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib44","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.surg.2013.09.005","article-title":"Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism","volume":"154","author":"Murray","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.006_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4158\/ep.10.5.404","article-title":"Symptoms in patients with primary hyperparathyroidism: muscle weakness or sleepiness","volume":"10","author":"Walker","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2018.06.006_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/110241598750005822","article-title":"Muscle strength and endurance after surgery for primary hyperparathyroidism","volume":"164","author":"Colliander","year":"1998","journal-title":"Eur J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0307-742X(21)00575-0","article-title":"Musculoskeletal manifestations of primary hyperparathyroidism","volume":"12","author":"Bhalla","year":"1986","journal-title":"Clin Rheum Dis"},{"key":"10.1016\/j.beem.2018.06.006_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002689910019","article-title":"Muscular performance and fatigue in primary hyperparathyroidism","volume":"24","author":"Deutch","year":"2000","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2265.2010.03906.x","article-title":"Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls: a cross-sectional study","volume":"74","author":"Amstrup","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.06.006_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/bjs.1800790223","article-title":"Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism","volume":"79","author":"Kristoffersson","year":"1992","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bjs.1800750128","article-title":"Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery","volume":"75","author":"Joborn","year":"1988","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5694\/j.1326-5377.1988.tb120508.x","article-title":"Neuromuscular symptoms in elderly patients with hyperparathyroidism: improvement with parathyroid surgery","volume":"149","author":"Delbridge","year":"1988","journal-title":"Med J Aust"},{"key":"10.1016\/j.beem.2018.06.006_bib53","first-page":"13","article-title":"Muscle structure and function before and after surgery for primary hyperparathyroidism","volume":"157","author":"Jansson","year":"1991","journal-title":"Eur J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-14-0940","article-title":"No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial","volume":"172","author":"Rolighed","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib55","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-014-3731-5","article-title":"Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study","volume":"21","author":"Blanchard","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2018.06.006_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00268-013-2273-5","article-title":"Muscle function is impaired in patients with \u2018\u2018Asymptomatic\u2019\u2019 primary hyperparathyroidism","volume":"38","author":"Rolighed","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib57","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SLA.0b013e3181d76bb3","article-title":"Parathyroidectomy improves functional capacity in \u2018\u2018asymptomatic\u2019\u2019 older patients with primary hyperparathyroidism: a randomized control trial","volume":"251","author":"Morris","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/bjs.10739","article-title":"Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism","volume":"105","author":"Bannani","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib59","doi-asserted-by":"crossref","first-page":"E1465","DOI":"10.1152\/ajpendo.00487.2006","article-title":"Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism","volume":"292","author":"Reppe","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib60","first-page":"153","article-title":"Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting","volume":"20","author":"Thomas","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.beem.2018.06.006_bib61","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar3769","article-title":"The independent association between parathyroid hormone levels and hyperuricemia: a national population study","volume":"14","author":"Hui","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.beem.2018.06.006_bib62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0002-9343(74)90638-X","article-title":"Diseases associated with calcium pyrophosphate dehydrate crystal deposition","volume":"56","author":"McCarty","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.06.006_bib63","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/1529-0131(197605\/06)19:3+<349::AID-ART1780190707>3.0.CO;2-Q","article-title":"Clinical studies of acute pseudogout attacks: comments on prevalence, predispositions and treatment","volume":"19","author":"O'Duffy","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.beem.2018.06.006_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fgene.2013.00076","article-title":"Major channels involved in neuropsychiatric disorders and therapeutic perspectives","volume":"4","author":"Imbrici","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.beem.2018.06.006_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-3223(88)90085-6","article-title":"Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism","volume":"23","author":"Joborn","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.beem.2018.06.006_bib66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0306-4530(91)90017-N","article-title":"Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism","volume":"16","author":"Joborn","year":"1991","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.beem.2018.06.006_bib67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/frne.2000.0203","article-title":"New members of the parathyroid hormone\/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues","volume":"21","author":"Usdin","year":"2000","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ceca.2009.11.013","article-title":"Calcium and normal brain ageing","volume":"47","author":"Toescu","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.beem.2018.06.006_bib69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00234-006-0198-5","article-title":"Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism","volume":"49","author":"Cermik","year":"2007","journal-title":"Neuroradiology"},{"key":"10.1016\/j.beem.2018.06.006_bib70","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib71","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib72","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/2013.jamasurg.316","article-title":"Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study","volume":"148","author":"Weber","year":"2013","journal-title":"JAMA Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib74","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.surge.2009.10.005","article-title":"Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population","volume":"8","author":"Leong","year":"2010","journal-title":"Surgeon"},{"key":"10.1016\/j.beem.2018.06.006_bib75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/EJE-11-0301","article-title":"Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls","volume":"165","author":"Amstrup","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.006_bib76","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0043-118347","article-title":"Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study","volume":"49","author":"Storvall","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2018.06.006_bib77","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s002689900428","article-title":"Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism","volume":"22","author":"Pasieka","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib78","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00268-008-9509-9","article-title":"Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism","volume":"32","author":"Mihai","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib79","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.surg.2009.10.021","article-title":"The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study","volume":"146","author":"Pasieka","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.006_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/000313481608200948","article-title":"Neuropsychological changes in primary hyperparathyroidism after parathyroidectomy","volume":"82","author":"Liu","year":"2016","journal-title":"Am Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib81","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1210\/jc.2015-3094","article-title":"Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism","volume":"101","author":"Webb","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib82","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF01655425","article-title":"Psychiatric morbidity in primary hyperparathyroidism","volume":"12","author":"Joborn","year":"1988","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib83","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1192\/bjp.145.5.477","article-title":"Hyperparathyroidism and paranoid psychosis. Case report and review of the literature","volume":"145","author":"Alarcon","year":"1984","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.beem.2018.06.006_bib84","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.06.006_bib85","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SLA.0b013e3181f66720","article-title":"The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing PTX for primary hyperparathyroidism","volume":"253","author":"Roman","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib86","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/lary.26617","article-title":"Early neurocognitive improvements following parathyroidectomy for primary hyperparathyroidism","volume":"128","author":"Shah-Becker","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.beem.2018.06.006_bib87","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","article-title":"Neuropsychological features in primary hyperparathyroidism: a prospective study","volume":"94","author":"Walker","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib88","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40618-015-0423-3","article-title":"Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms","volume":"39","author":"Trombetti","year":"2016","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2018.06.006_bib89","doi-asserted-by":"crossref","first-page":"E1737","DOI":"10.1210\/jc.2011-1486","article-title":"Depression in primary hyperparathyroidism: prevalence and benefit of surgery","volume":"96","author":"Espiritu","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2265.2011.04197.x","article-title":"The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism","volume":"76","author":"Kahal","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.06.006_bib91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jc.2013-3115","article-title":"What is the best way of assessing neurocognitive dysfunction in patients with primary hyperparathyroidism?","volume":"99","author":"Grant","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib92","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00423-011-0885-5","article-title":"Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism","volume":"397","author":"Babi\u0144ska","year":"2012","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib93","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1017\/S1355617709990695","article-title":"Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy","volume":"15","author":"Benge","year":"2009","journal-title":"J\u00a0Int Neuropsychol Soc"},{"key":"10.1016\/j.beem.2018.06.006_bib94","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","article-title":"Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \"asymptomatic\" primary hyperparathyroidism","volume":"146","author":"Perrier","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.006_bib95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.surg.2017.09.001","article-title":"Neurocognitive performance profile postparathyroidectomy: a pilot study of computerized assessment","volume":"163","author":"Bell","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.006_bib96","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2017.06.001","article-title":"Occurrence of malignant neoplasia in patients with primary hyperparathyroidism","volume":"43","author":"Palmieri","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.beem.2018.06.006_bib97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.1.01261","article-title":"The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy","volume":"14","author":"Nilsson","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2018.06.006_bib98","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.4103\/2230-8210.104042","article-title":"Hyperparathyroidism: cancer and mortality","volume":"16","author":"Goswami","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.006_bib99","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/oxfordjournals.aje.a114879","article-title":"Increased risk of malignant diseases after surgery for primary hyperparathyroidism \u2013 a Nationwide Cohort Study","volume":"127","author":"Palm\u00e9r","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.beem.2018.06.006_bib100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/cncr.10846","article-title":"Hyperparathyroidism and subsequent cancer risk in Denmark","volume":"95","author":"Pickard","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2018.06.006_bib101","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"Premature death in patients operated on for primary hyperperathyroidism","volume":"14","author":"Hedback","year":"1990","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib102","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00268-003-7046-0","article-title":"Increased mortality in patients hospitalised with primary hyperparathyroidism during the period 1977-1993 in Denmark","volume":"28","author":"Ogard","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib103","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","article-title":"Survival after surgical treatment for primary hyperparathyroidism","volume":"122","author":"S\u00f6reide","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.006_bib104","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1054\/mehy.1999.0880","article-title":"Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D","volume":"54","author":"McCarty","year":"2000","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.beem.2018.06.006_bib105","first-page":"95","article-title":"Colorectal cancer and solar radiation","volume":"3","author":"Emerson","year":"1992","journal-title":"Cancer Cause Control"},{"key":"10.1016\/j.beem.2018.06.006_bib106","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0091-7435(90)90058-R","article-title":"Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation","volume":"19","author":"Garland","year":"1990","journal-title":"Prev Med"},{"key":"10.1016\/j.beem.2018.06.006_bib107","first-page":"1307","article-title":"Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis)","volume":"10","author":"Schwartz","year":"1990","journal-title":"Anticancer Res"},{"key":"10.1016\/j.beem.2018.06.006_bib108","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/ije\/23.6.1133","article-title":"Sunlight, vitamin D, and ovarian cancer mortality rates in US women","volume":"23","author":"Lefkowitz","year":"1994","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.beem.2018.06.006_bib109","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.ejca.2006.02.024","article-title":"Does sunlight prevent cancer? A systematic review","volume":"42","author":"Van der Rhee","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beem.2018.06.006_bib110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/pmed.1993.1010","article-title":"Beneficial effects of sun exposure on cancer mortality","volume":"22","author":"Ainsleigh","year":"1993","journal-title":"Prev Med"},{"key":"10.1016\/j.beem.2018.06.006_bib111","first-page":"767","article-title":"Parathyroid hormone-related protein is a growth factor for prostate cancer","volume":"81","author":"Bowcott","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2018.06.006_bib112","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/bjc.1997.513","article-title":"PTHrP and the PTH\/PTHrP receptor are co-expressed in human breast and colon tumours","volume":"76","author":"Carron","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beem.2018.06.006_bib113","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0090-4295(94)90183-X","article-title":"Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines","volume":"43","author":"Iwamura","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.beem.2018.06.006_bib114","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<212::AID-PATH920>3.0.CO;2-O","article-title":"Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue","volume":"183","author":"Downey","year":"1997","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.beem.2018.06.006_bib115","first-page":"83","article-title":"The epidemiology of vitamin D and cancer incidence and mortality: a review (United States)","volume":"16","author":"Giovannucci","year":"2005","journal-title":"Cancer Cause Control"},{"key":"10.1016\/j.beem.2018.06.006_bib116","first-page":"2000","article-title":"Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism","volume":"85","author":"Carling","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:53:31Z","timestamp":1761497611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18300885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":116,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1521690X18300885"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.006","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non classical complications of primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}